In vivo research suggests that EPA and DHA may reduce obesity and decrease adipogenesis by overexpressing peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) and downregulating G‐protein‐coupled receptor 120 (GPR‐120) (Wei et al. 2021). The gene discussed is PPARG; the disease is obesity disorder.